Feline Immunodeficiency Virus Induces Secretory IgA Responses

Pre-existing mucosal generated secretory IgA antibodies may prevent transmission of HIV. The present study aimed to characterize mucosal antibodies generated following topical vaccination with a novel mucosal adjuvant, angiotensin, in combination with a killed feline immunodeficiency virus vaccine used as a model antigen.Female outbred cats were vaccinated with Fel-O-Vax FIV vaccine agent combined with increasing concentrations of angiotensin  applied topically to oral, vaginal and rectal surfaces weekly for six weeks.

Immunodeficiency Virus

Control animals received intramuscular vaccinations with the Fel-O-Vax FIV alone or with A. Mucosal secretions were evaluated for antibody responses against FIV-p24 antigen or HIV-gp120 antigen.Topical application of whole killed FIV virus with A induced substantial secretory IgA -antigp120 antibodies in oral, vaginal and rectal secretions across a wide ranges of A dose levels. Intramuscular vaccination of FIV antigen with A induced high levels of SIgA-anti-gp120 antibodies at vaginal and rectal sites. The topical application vaccination strategy elicited only very weak systemic immune responses.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s